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Abstract
Chronic use of cocaine is associated with a reduced density of dopaminergic D2 receptors in the striatum, with negative
consequences for cognitive control processes. Increasing evidence suggests that cognitive control is also affected in
recreational cocaine consumers. This study aimed at linking these observations to dopaminergic malfunction by studying
the spontaneous eyeblink rate (EBR), a marker of striatal dopaminergic functioning, in adult recreational users and a
cocaine-free sample that was matched on age, race, gender, and personality traits. Correlation analyses show that EBR is
significantly reduced in recreational users compared to cocaine-free controls, suggesting that cocaine use induces
hypoactivity in the subcortical dopamine system.
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Introduction
In the long term, daily or chronic use of cocaine is associated
with a reduction in dopamine D2 (DAD2) receptors in the
striatum [1] and with hypoactivity dysfunctions in the lateral
prefrontal cortex, the anterior cingulate cortex, and the orbito-
frontal cortex [2,3,4]-areas that play a key role in the regulation of
human cognition and the control of goal-directed behaviour [5,6].
Findings that cocaine-dependent individuals show impaired
abilities to inhibit overt responses [7] support the notion that
cocaine, through its selective effect on DAD2 receptors [1],
modulates cognitive control in general [8] and response inhibition
in particular [9].
Recent studies suggest that recreational users of cocaine, who do
not meet the criteria for abuse or dependence but take cocaine on
a monthly basis (1 to 4 gram, commonly consumed in only a few
sessions, so that the peak use [bingeing] often equals this monthly
dose) exhibit cognitive symptoms similar to those of chronic users.
Colzato, van den Wildenberg, and Hommel [10] showed that
recreational use impairs response inhibition to a degree that is
proportional to lifetime cocaine exposure. This indicates that the
inhibitory deficit increases as a function of the history of cocaine
use [2,11]. Colzato and Hommel found that, relative to a sample
of cocaine-free controls, recreational users show increased costs in
switching between different tasks [12] and no reliable inhibition of
return (IOR) [13]-the (commonly robust) phenomenon of slowed
responding when attention needs to return to a previously
attended location [14].
The observation that recreational use of cocaine is associated
with impairments in response inhibition, cognitive flexibility, and
IOR—all functions that are assumed to rely on dopaminergic
pathways [9,15,16]—suggests that recreational use is sufficient to
hamper the dopaminergic support of cognitive control functions.
However, the relation between mental control functions and
cocaine is not straightforward because pre-existent neuro-devel-
opmental factors cannot be excluded. Recent studies showed,
indeed, that those individuals with pre-existing lowered D2
receptor densities are more at risk to use cocaine and to become
addicted [17] and that chronic users may suffer from pre-existing
inhibitory deficits [18].
The present study sought for converging evidence supporting
the hypothesis that recreational use of cocaine is associated with
impairments in the dopaminergic system. The dependent
measure of interest for our purposes was the spontaneous eye-
blink rate (EBR), a well established clinical indicator [19] that is
generally interpreted as a marker of dopaminergic functioning in
the striatum [21–24, but see 20]. First, the functional link
between the striatum and EBR is supported by clinical
observations in patients with DA-related dysfunctions: Whereas
EBR is elevated in schizophrenic patients with increased
dopaminergic activity in the striatum [25], EBR is reduced in
Parkinson’s patients who suffer from a loss of nigrostriatal
dopaminergic cells [26]. Second, the link is sustained by
pharmacological studies in nonhuman primates showing that
direct DA agonists and antagonists respectively increase and
decrease blink rates [23]. Third, a genetic study in humans
demonstrated a strong association between EBR and the DRD4/
7 genotype, which is related to the control of striatal DA release
[27].
Following this reasoning, and given that cocaine use is
associated with reduced D2 receptors [1], we expected that
recreational users would show a significantly reduced EBR
compared to a matched sample of cocaine-free controls. Second,
given that the magnitude of cognitive impairments in response
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we expected a negative correlation between cocaine exposure and
EBR, indicating that the magnitude of dopaminergic malfunction
is proportional to life-time cocaine use.
Results
Data were examined using Brain Vision Analyzer (Brain
Products
TM GmbH, Munich, Germany; http://www.brainproducts.
com/products/analyzer/index_analyzer.html). We defined an eye-
blink as a voltage change of 100 mV in a time interval of 500 ms.
EBR per minute was significantly lower, t(22)=23,42, p,.05, in
recreational users, (M=9.3; SD=5.9), than in cocaine-free controls
(M=17.1; SD=5.3)—a possible indication of hypoactive subcortical
dopamine systems in cocaine users.
Second, we tested whether alcohol and nicotine consumption
and IQ contributed to the effect on eyeblink measures. However,
an ANOVA with group (recreational cocaine users vs. cocaine-
free controls) as independent variable and monthly drinks,
monthly cigarettes and IQ as covariates did not suggest such
contribution: the effects of the covariates were far from
significant, F,1, while the group effect remained reliable, F(1,
20)=4.38, p,.05.
Third, to test whether the magnitude of dopaminergic
malfunction is proportional to the amount of cocaine consumed,
we computed Spearman’s Rho correlation coefficients between
individual lifetime cocaine exposure, highest regular frequency,
peak and monthly cocaine dose, and EBR per minute. Peak
correlated negatively with EBR, r(12)=2.67, p,.05, while lifetime
cocaine exposure, r(12)=2.12, highest regular frequency,
r(12)=2.50, and monthly cocaine dose, r(12)=2.28, did not.
Hence, the larger the amount of cocaine consume in a 12-h
period, the lower the eye blink rate and, by inference, the more
pronounced the dopaminergic malfunction.
Discussion
Our finding shows that the spontaneous EBR, a functional
marker of dopaminergic functioning [19], is significantly reduced
in recreational cocaine users as compared to cocaine-free
controls. Moreover, the degree of this reduction corresponds to
the peak of cocaine consume, suggesting that higher peaks are
associated with increased dopaminergic hypoactivity. The
pattern observed fits with the notion that chronic use of cocaine
produces a reduced functioning of DAD2 receptors in the
striatum [1]. Apparently, then, even small doses of cocaine are
associated with a reliable change in striatal dopaminergic
functioning.
As Bolla et al. [2] previously pointed out, the effects of
chemicals on the central nervous system are generally subtle and
may occur only at higher doses. This is why Bolla and colleagues
consider it critical to compare individuals with highest exposure
to individuals with low or no exposure. According to these
authors, exposure duration is critical to the development of
neurocognitive effects after organic and inorganic lead exposure,
whereas exposure intensity is more critical for the development
of neurocognitive effects following exposure to organic solvents.
Along these lines, Cascella et al. [28] found that the amount of
alcohol consumption per session at the time of peak use
(bingeing) was a better predictor of brain atrophy than current
alcohol consumption. According to this logic, it makes sense that
we found cocaine bingeing to be a better predictor of EBR and
the hypothesized underlying dopaminergic malfunction than
current cocaine consumption.
In contrast to numerous previous studies on chronic cocaine
use (see [29]), the design of our study allows us to reject a
number of alternative accounts of our observations. Participants
were screened for several psychiatric disorders and matched for
age, race, IQ, gender, alcohol consumption, and personality
traits, which rules out interpretations in terms of pre-existing
psychiatric disorders (such as schizophrenia, ADHD, and
obsessive compulsive disorder) that are known to affect the
dopaminergic system [30,31,32] This finding is in line with
evidence that Parkinson’s patients, who suffer from loss of
nigrostriatal dopaminergic cells, show cognitive impairments and
lower EBR than controls [26]. Particularly important was the
matching of the personality traits: From previous studies on EBR
it is known that higher scores on psychoticism scales are
associated with elevated EBR [33]. Even though our recreational
users also used other recreational drugs in the past, marijuana
and MDMA in particular, we doubt that our results can be
attributed to the use of these substances: MDMA is associated
primarily with impairments in serotonine supply [34] and the
long-term after-effect of cannabis (in contrast to effects in current
users) is not known to be neurotoxic [35].
To conclude, the findings obtained in this study are important
in suggesting a selective dopaminergic malfunction resulting from,
or at least connected with, the consumption of rather small doses
of cocaine. However, as mentioned earlier, recent evidence
suggests that subjects with pre-existing lowered D2 receptor
densities run a higher risk to use cocaine and to become addicted
[17]. The status of cocaine use as cause versus effect in the context
of this and other disorders of impulse control, such as ADHD and
pathological gambling, is still uncertain and more research is
needed to determine the relative contributions of cocaine
consumption and other pre-existing constellations to impairments
of the dopaminergic system.
Materials and Methods
Participants
Twenty-four young healthy adults served as participants,
consisting of two groups of 12 recreational users of cocaine and
12 cocaine-free controls. One recreational cocaine user received
course credit while the other participants received a financial
reward. The sample was drawn from adults in the Leiden,
Rotterdam, and Delft metropolitan areas, who volunteered to
participate in studies of behavioural pharmacology. Participants
were recruited via notices posted on community bulletin boards
and by word of mouth.
Following Colzato et al. [12], we made sure that the users met
the following criteria: 1) a monthly consumption of cocaine (1 to
4 gram) by snorting route for a minimum of two years; 2) no Axis
1 psychiatric disorder (DSM-IV [36]), including ‘substance
abuse’; 3) no clinically relevant medical disease; 4) no use of
medication; 5) no family history of alcoholism and/or substance
use disorder. Cocaine-free controls met the same criteria except
that they reported no history of past or current cocaine use.
Subjects were selected by means of a phone interview by a
research assistant with the M.I.N.I. [37], a brief diagnostic tool
that screens for several psychiatric disorders including, among
others, schizophrenia, depression, mania, and obsessive-compul-
sive disorder. Participants with a known history of psychopa-
thology and those who were taking medication were excluded.
The sample was obtained from a pool of approximately 35
potential volunteers who responded to the advertisement
‘‘recreational cocaine users and cocaine free controls’’ for studies
conducted in our lab over the period of 6 months. Within this
Dopamine and Cocaine
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excluding an individual from the study was meeting psychiatric
disorder (ADHD, Mania) or medication use.
In line with Colzato, van Wouwe, and Hommel [38],
participants were asked to refrain from taking drugs for two days
and from all caffeine containing foods and beverages for 12 hours
prior to the experiment, not to consume alcohol on the night
before the experimental session and to have a normal night rest.
Subjects’ compliance with the instruction was encouraged by
taking a saliva sample (not further analyzed) at the beginning of
the session (cf., [39]).
During the month that preceded testing, three out of twelve
recreational users also smoked marijuana, while two reported to
have taken one MDMA (ecstasy) tablet. The cocaine-free
controls reported not having used any drug. Participants in the
two groups were matched for race (100% Caucasian), age,
gender, IQ (measured by Raven’s Standard Progressive Matrices
(SPM [40]), alcohol consumption, and personality traits psycho-
ticism, extraversion, neuroticism, and social approval (measured
by the Eysenck Personality Questionnaire Revised Short Scale
[41]).
Demographic and drug use statistics are provided in Tables 1
and 2. In Table 2, t-tests were calculated to compare the
demographic characteristic of the two groups. Written informed
consent was obtained from all participants after the nature of the
study was explained to them. Protocol and subject honoraries were
approved by the institutional review board (Leiden University,
Institute for Psychological Research).
Procedure and design
A BioSemi ActiveTwo system (BioSemi Inc., Amsterdam, The
Netherlands) was used to record the EBR. Eyeblinks were
recorded with two horizontal electrodes in the outer canthi of
both eyes (HEOG) and two vertical electrodes in the infraorbital
and supraorbital regions of the left eye (VEOG). EBR was
recorded for 6-min eyes-open segments under resting conditions.
The horizontal electro-oculogram, which records the voltage
difference between electrodes placed lateral to the external
canthi, was used to measure horizontal eye movements. The
vertical electro-oculogram, which records the voltage difference
between two electrodes placed above and below the left eye, was
used to detect eye blinks. A low-pass filter of 40 Hz was applied
and electro-oculogram signals, digitized at 512 Hz, were
averaged offline. Given that spontaneous EBR is supposed to
be stable during daytime but increases in the evening (8:30 p.m.,
as reported by [42]), all data were collected before 5 p.m. To
minimize influences of demographic variables on EBR, we paid
attention to match our subjects for age and gender, given that
women exhibited a higher tonic EBR than men. Subjects were
comfortably sitting in front of a blank poster with a cross in the
centre, located about 1 meter from the subject. The subject was
alone in the room and was instructed to look at the cross in a
quiet relaxed state for six minutes.
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Table 1. Demographic characteristics, EPQ-R scores, and use of other recreational drugs.
Controls Recreational users Significance level
N (M:F) 12 (10:2) 12 (10:2) ns
Age (years) 28.3 (5.2) 27.5 (5.6) ns
Raven IQ 124.2 (4.5) 116.3 (3.7) ns
Monthly drinks 60.0 (61.6) 90.5 (61.6) ns
Monthly cigarettes 144.1 (291.8) 240.8 (196.7) **
Lifetime exposure cannabis - 483.3 (174.9) **
Lifetime exposure MDMA - 65.2 (51.8) **
Psychoticism trait 3.5 (1.0) 4.4 (1.6) ns
Extraversion trait 9.9 (2.2) 10.7 (1.2) ns
Neuroticism trait 3.1 (2.9) 5.1 (2.7) ns
Social Approval trait 4.5 (2.1) 3.2 (4.5) ns
Standard deviation in parentheses. Ns, Non-significant difference; Raven IQ, IQ measured by means of the Raven Progressive Matrices; Monthly drinks, monthly number
of standard alcoholic drinks; Monthly cigarettes, monthly standard cigarettes smoked; Lifetime exposure cannabis, lifetime consumption of joints; Lifetime exposure
MDMA, lifetime consumption of MDMA (ecstasy) tablets; Personality traits measured by means of the Eysenck Personality Questionnaire Revised Short Scale.
**p,0.01.
doi:10.1371/journal.pone.0003461.t001
Table 2. Self-reported use of cocaine. Standard deviation in
parentheses.
Sample Mean (SD)
Highest regular frequency (times per month) 3.5 (2.9)
Highest amount in a 12-h period (peak; grams) 1.30 (0.82)
Monthly grams 2.15 (1.18)
Lifetime exposure grams 270 (193)
Monthly money cocaine (Euro) 107.5 (58.9)
doi:10.1371/journal.pone.0003461.t002
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